BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16773697)

  • 1. Loss of heterozygosity and microsatellite instabilities of fragile histidine triad gene in gastric carcinoma.
    Xiao YP; Wu DY; Xu L; Xin Y
    World J Gastroenterol; 2006 Jun; 12(23):3766-9. PubMed ID: 16773697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MSI/LOH and extron expression of the FHIT gene in gastric carcinoma.
    Xiao Y; Mao L; Han C; Li J; Xu L; Xin Y
    Front Med China; 2007 Feb; 1(1):99-103. PubMed ID: 24557626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency of LOH, MSI and abnormal expression of FHIT in gastric cancer.
    Huiping C; Kristjansdottir S; Bergthorsson JT; Jonasson JG; Magnusson J; Egilsson V; Ingvarsson S
    Eur J Cancer; 2002 Mar; 38(5):728-35. PubMed ID: 11916557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsatellite instability and loss of heterozygosity of fragile histidine triad gene in lung hyperplastic lesions.
    Zhang JX; Shen H
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Apr; 23(4):313-7. PubMed ID: 12697461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FHIT gene and flanking region on chromosome 3p are subjected to extensive allelic loss in Egyptian breast cancer patients.
    Ismail HM; Medhat AM; Karim AM; Zakhary NI
    Mol Carcinog; 2011 Aug; 50(8):625-34. PubMed ID: 21557333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Allelic loss and down-regulation of FHIT gene expression in esophageal squamous cell carcinoma].
    Liu FX; Huang XP; Zhao CX; Xu X; Han YL; Cai Y; Wu RL; Wu M; Zhan QM; Wang MR
    Ai Zheng; 2004 Sep; 23(9):992-8. PubMed ID: 15363189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of the fragile histidine triad gene in primary gastric adenocarcinomas.
    Lee SH; Kim WH; Kim HK; Woo KM; Nam HS; Kim HS; Kim JG; Cho MH
    Biochem Biophys Res Commun; 2001 Jun; 284(3):850-5. PubMed ID: 11396980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the relationship between LOH and MI of FHIT gene and the development of cervical carcinoma].
    Liu H; Peng ZL; Wang H; Liu SL; Zhang CS; Tang QP; He B
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jul; 36(4):506-9. PubMed ID: 16078573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FHIT gene in gastric cancer: association with tumour progression and prognosis.
    Noguchi T; Müller W; Wirtz HC; Willers R; Gabbert HE
    J Pathol; 1999 Aug; 188(4):378-81. PubMed ID: 10440747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association of fragile histidine triad gene (FHIT) with susceptibility to esophageal cancer. A preliminary study].
    Li W; Wang X; Cheng G
    Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):258-60. PubMed ID: 10920977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Identification of some macrosatillite sites of chromosome 19 in primary gastric carcinoma with loss of heterozygosity].
    Jiang M; Xu L; Zhao Y; Fang HH; Chen ZH; Gao Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 32(3):455-9. PubMed ID: 17611325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent FHIT gene loss of heterozygosity in human papillomavirus-infected non-smoking female lung cancer in Taiwan.
    Wang J; Cheng YW; Wu DW; Chen JT; Chen CY; Chou MC; Lee H
    Cancer Lett; 2006 Apr; 235(1):18-25. PubMed ID: 15935551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Microsatellite instability and loss of heterozygosity of fragile histidine triad gene in laryngeal squamous cell carcinoma].
    Yin DT; Dong MM
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2005 Jan; 40(1):45-8. PubMed ID: 15906520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-hit inactivation of FHIT by loss of heterozygosity and hypermethylation in breast cancer.
    Yang Q; Nakamura M; Nakamura Y; Yoshimura G; Suzuma T; Umemura T; Shimizu Y; Mori I; Sakurai T; Kakudo K
    Clin Cancer Res; 2002 Sep; 8(9):2890-3. PubMed ID: 12231533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the fragile histidine triad (FHIT) gene in lobular breast cancer.
    Huiping C; Jonasson JG; Agnarsson BA; Sigbjornsdottir BI; Huebner K; Ingvarsson S
    Eur J Cancer; 2000 Aug; 36(12):1552-7. PubMed ID: 10930803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent allelic deletion at the FHIT locus associated with p53 overexpression in squamous cell carcinoma subtype of Taiwanese non-small-cell lung cancers.
    Lee YC; Wu CT; Shih JY; Jou YS; Chang YL
    Br J Cancer; 2004 Jun; 90(12):2378-83. PubMed ID: 15150628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragile histidine triad gene abnormalities in the pathogenesis of gallbladder carcinoma.
    Wistuba II; Ashfaq R; Maitra A; Alvarez H; Riquelme E; Gazdar AF
    Am J Pathol; 2002 Jun; 160(6):2073-9. PubMed ID: 12057912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Microsatellite instability and allele-specific chromosome 3p deletion in breast cancer and precancerous lesions].
    Fu Q; Yao GY; Tang XL; Chen LR; Zheng ZX
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):34-40. PubMed ID: 17575691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Loss of heterozygosity of tumor suppressor genes at chromosome 3p in transitional cell carcinoma of urinary bladder].
    Xiao Z; Zhang J; Zheng S; Li C; He Z; Cheng S; Gao Y
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1375-7. PubMed ID: 12509916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrations in the fragile histidine triad(FHIT) gene may be involved in lung carcinogenesis in patients with chronic pulmonary tuberculosis.
    Song L; Yan W; Deng M; Song S; Zhang J; Zhao T
    Tumour Biol; 2004; 25(5-6):270-5. PubMed ID: 15627891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.